100% In House

PHARMACEUTICALS
(time to market)

Under development:

  • 3 Injectable/lyophilised (>2 years)
  • 2 β-lactam antibiotic (>2 years)

Planned submission:

  • 1 β-lactam antibiotic (2 years)

Under submission:

  • 3 Injectable/lyophilised (1 year)
  • 2 β-lactam antibiotic (1 year)

Out of Patent

Collaboration (RJF + University + Start-up)

PHARMACEUTICALS / MEDICAL DEVICE / FOOD SUPPLEMENT (time to market)

Under development:

  • Biosimilar (>2 years)

Clinical data presentation:

  • Fungic infection – Phase III (>2 years)
  • Nife-Par – Post Approval
  • GynEC – Post Approval

Under submission:

  • Impetigo (1 year)

Pre-market:

  • Nail regeneration
  • Men fertility
  • Molluscum

Patented

Innovation